![Matthew Outten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Outten
Corporate Officer/Principal chez
BRIDGEBIO PHARMA, INC.
Profil
Matthew Outten is currently the Chief Commercial Officer at QED Therapeutics, Inc. and also holds the position of Chief Commercial Officer at BridgeBio Pharma, Inc. He previously worked as the Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Outten completed his undergraduate degree at Hamilton College (New York) and earned an MBA from the University of Delaware.
Postes actifs de Matthew Outten
| Sociétés | Poste | Début |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/02/2019 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | - |
Anciens postes connus de Matthew Outten
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Formation de Matthew Outten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
